Vlastníctvo manažmentu spoločnosti 10x Genomics

Aká je hodnota metriky Vlastníctvo manažmentu spoločnosti 10x Genomics?

Hodnota metriky Vlastníctvo manažmentu spoločnosti 10x Genomics, Inc. je 2.46%

Aká je definícia metriky Vlastníctvo manažmentu?

Vlastníctvo manažmentu (Insider Ownership) je pomer akcií vlastnených akcionármi v rámci firmy (vlastniaci viac než 5% spoločnosti alebo s titulom riaditeľa či vedúceho oddelenia) a všetkých vydaných akcií.

A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.

A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.

Čomu sa venuje spoločnosť 10x Genomics?

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Firmy s metrikou vlastníctvo manažmentu podobnou spoločnosti 10x Genomics

  • Hodnota metriky Vlastníctvo manažmentu spoločnosti Lantheus Inc je 2.45%
  • Hodnota metriky Vlastníctvo manažmentu spoločnosti Verimatrix Societe anonyme je 2.45%
  • Hodnota metriky Vlastníctvo manažmentu spoločnosti Intra-Cellular Therapies Inc je 2.45%
  • Hodnota metriky Vlastníctvo manažmentu spoločnosti NewAge Inc je 2.45%
  • Hodnota metriky Vlastníctvo manažmentu spoločnosti Pucara Gold je 2.45%
  • Hodnota metriky Vlastníctvo manažmentu spoločnosti Insmed Inc je 2.46%
  • Hodnota metriky Vlastníctvo manažmentu spoločnosti 10x Genomics je 2.46%
  • Hodnota metriky Vlastníctvo manažmentu spoločnosti Federal Signal je 2.47%
  • Hodnota metriky Vlastníctvo manažmentu spoločnosti Beazley Plc je 2.47%
  • Hodnota metriky Vlastníctvo manažmentu spoločnosti NeoPhotonics je 2.47%
  • Hodnota metriky Vlastníctvo manažmentu spoločnosti ChannelAdvisor Corp je 2.47%
  • Hodnota metriky Vlastníctvo manažmentu spoločnosti Pacton Gold je 2.47%
  • Hodnota metriky Vlastníctvo manažmentu spoločnosti Abercrombie & Fitch Co je 2.47%